Search - tctmd.com

Displaying 361 - 380 of 591

Sort: Relevancy | Date

Presentation TVT 2023

First in Human Experience with the CroiValve DUO Novel Tricuspid Coaptation Valve: THE TANDEM 1 Trial

Presenter: Wojciech Wojakowski

June 09, 2023

News Daily News

Reports of Arrhythmias, Cardiac Arrests Linked to Nonprescription Opioids

Todd Neale

June 09, 2023

Presentation TVT 2023

The Cardiovalve TTVR System: Human Clinical Experience (TARGET Trial)

Presenter: Matti Adam

June 09, 2023

News Conference News LINC 2023

Early Data on Temporary Spur in BTK PAD Show Efficacy, Limited Recoil

L.A. McKeown

June 09, 2023

News Conference News TVT 2023

Solid Anchoring, Good Echo Results With Transapical TMVR at 2 Years

Michael O'Riordan

June 09, 2023

Presentation TVT 2023

LATE BREAKING INNOVATION: Transcatheter Edge-to-Edge Repair for Tricuspid Regurgitation: Comparing the TRILUMINATE™ Pivotal and bRIGHT Clinical Trials

Presenter: Paul Sorajja

June 09, 2023

Presentation TVT 2023

Impact of Malnutrition in Patients with Heart Failure and Secondary Mitral Regurgitation: COAPT Trial

Presenter: Andrea Scotti

June 09, 2023

Presentation TVT 2023

Highlighting the Importance and Pitfalls in Interpreting Patient Reported Outcomes

Presenter: David Cohen

June 08, 2023

Presentation TVT 2023

Lessons Learned from the TRILUMINATE Trial: Balancing the Safety and Efficacy of Transcatheter Tricuspid Valve Repair

Presenter: Paul Sorajja

June 08, 2023

Presentation TVT 2023

Update From the Clinical Trials and Where I Would and Wouldn’t Use It

Presenter: Basel Ramlawi

June 08, 2023

Presentation TVT 2023

Update From the Clinical Trials and Where I Would and Wouldn’t Use It

Presenter: Azeem Latib

June 08, 2023

Presentation TVT 2023

Etiologies of Exclusion Rates for Transcatheter Mitral and Tricuspid Valve Structural Heart Clinical Trials at a High volume Quaternary Care Hospital

Presenter: Lu Chen

June 08, 2023

Presentation TVT 2023

Lessons Learned from the PROTECTED TAVR Trial: Mapping the Future of Cerebral Embolic Protection

Presenter: Samir Kapadia

June 08, 2023

Presentation TVT 2023

VitaFlow System: The SEASON-AR Trial

Presenter: Junjie Zhang

June 08, 2023

Presentation TVT 2023

InterShunt: EASE-HF Trial Results

Presenter: Robin Germany

June 08, 2023

News Conference News LINC 2023

What Works, What’s Noise? Novel Approaches Offer Hope in CLTI

L.A. McKeown

June 07, 2023

News Conference News LINC 2023

Good Real-World Outcomes Seen With Next-Generation Carotid Stent

L.A. McKeown

June 06, 2023

News Daily News

CABG and PCI Comparable in ACS Patients With Left Main CAD

Michael O'Riordan

June 06, 2023

News Daily News

FDA Grants First HF Indication for IV Iron to Ferric Carboxymaltose

Shelley Wood

June 05, 2023

News Daily News

Andexanet Alfa, Reversal Agent for Factor Xa Inhibitors, Boosts Hemostasis

Todd Neale

June 05, 2023

Advertisement

First in Human Experience with the CroiValve DUO Novel Tricuspid Coaptation Valve: THE TANDEM 1 Trial

Reports of Arrhythmias, Cardiac Arrests Linked to Nonprescription Opioids

The Cardiovalve TTVR System: Human Clinical Experience (TARGET Trial)

Early Data on Temporary Spur in BTK PAD Show Efficacy, Limited Recoil

Solid Anchoring, Good Echo Results With Transapical TMVR at 2 Years

LATE BREAKING INNOVATION: Transcatheter Edge-to-Edge Repair for Tricuspid Regurgitation: Comparing the TRILUMINATE™ Pivotal and bRIGHT Clinical Trials

Impact of Malnutrition in Patients with Heart Failure and Secondary Mitral Regurgitation: COAPT Trial

Highlighting the Importance and Pitfalls in Interpreting Patient Reported Outcomes

Lessons Learned from the TRILUMINATE Trial: Balancing the Safety and Efficacy of Transcatheter Tricuspid Valve Repair

Update From the Clinical Trials and Where I Would and Wouldn’t Use It

Update From the Clinical Trials and Where I Would and Wouldn’t Use It

Etiologies of Exclusion Rates for Transcatheter Mitral and Tricuspid Valve Structural Heart Clinical Trials at a High volume Quaternary Care Hospital

Lessons Learned from the PROTECTED TAVR Trial: Mapping the Future of Cerebral Embolic Protection

VitaFlow System: The SEASON-AR Trial

InterShunt: EASE-HF Trial Results

What Works, What’s Noise? Novel Approaches Offer Hope in CLTI

Good Real-World Outcomes Seen With Next-Generation Carotid Stent

CABG and PCI Comparable in ACS Patients With Left Main CAD

FDA Grants First HF Indication for IV Iron to Ferric Carboxymaltose

Andexanet Alfa, Reversal Agent for Factor Xa Inhibitors, Boosts Hemostasis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content